This is a double-blind, randomized multicenter Phase III study comparing TNFR:Fc 10mg and 25mg to methotrexate (MTX) (7.5mg to 20mg) in MTX naive patients with early, active rheumatoid arthritis. Safety and efficacy evaluations will be performed at regular intervals.
Showing the most recent 10 out of 859 publications